[HTML][HTML] Longitudinal assessment of the nevus phenotype in a melanoma kindred

SR Florell, LJ Meyer, KM Boucher, PA Porter-Gill… - Journal of investigative …, 2004 - Elsevier
SR Florell, LJ Meyer, KM Boucher, PA Porter-Gill, M Hart, J Erickson, LA Cannon-Albright
Journal of investigative dermatology, 2004Elsevier
Phenotypic characteristics of members of a melanoma prone kindred with a V126D
CDKN2A gene mutation were monitored over approximately 15 y. Thirty-eight previously
studied subjects were recruited. Participants underwent a complete skin examination by the
same dermatologist who examined them initially. The size and location of all nevi were
recorded on a body map diagram. Total nevus number (TNN) and total nevus density (TND)
were determined. CDKN2A sequencing verified 13 mutation carriers and 16 non-carriers …
Phenotypic characteristics of members of a melanoma prone kindred with a V126D CDKN2A gene mutation were monitored over approximately 15 y. Thirty-eight previously studied subjects were recruited. Participants underwent a complete skin examination by the same dermatologist who examined them initially. The size and location of all nevi were recorded on a body map diagram. Total nevus number (TNN) and total nevus density (TND) were determined. CDKN2A sequencing verified 13 mutation carriers and 16 non-carriers. Nine participants were spouse controls without a history of melanoma and did not carry a CDKN2A mutation. Mutation carriers demonstrated a greater mean TNN and TND at initial and follow-up examinations compared with non-carriers and continued to develop nevi rather than show nevus regression seen in non-carriers and spouse controls. Non-carriers showed an intermediate nevus phenotype between mutation carriers and spouse controls. Four of the 13 mutation carriers and one non-carrier have developed invasive melanoma. Over a 15-y interval, TNN and TND were increased in mutation carriers compared with non-carriers and spouse controls. Continued accumulation of nevi in mutation carriers supports a nevogenic role for this CDKN2A mutation. An intermediate nevus phenotype in non-carrier family members suggests the presence of additional modifier genes.
Elsevier